Steven Mah

Steven Mah is a Managing Director on the Equity Research team in the life science & diagnostic tools sector. Prior to joining TD Cowen, Dr. Mah was a senior analyst for life science & diagnostic tools at Piper Sandler, and earlier in his career was a Principal in Piper Sandler’s health care investment banking group, where he focused on mergers and acquisitions as well as equity and equity-linked transactions.

At TD Cowen his expertise in dynamic emerging market segments such as synthetic biology and artificial-intelligence driven health solutions will further the health care research sector.

Dr. Mah holds a B.S. in molecular biology from the University of California, Los Angeles; a Ph.D. in molecular biology from the University of California, San Diego; and an MBA from Cornell University’s Johnson Graduate School of Management.